US FDA Has Model Drug Facts Labels For OTC Naloxone, Needs Switch Proposals by Brian Shim | Nov 2, 2022 | News
OTC Naloxone One Step Closer as Harm Reduction Therapeutics Initiates a Rolling Submission of its New Drug Application to U.S. FDA for RiVive™ for Emergency Treatment of Opioid Overdose by Brian Shim | Oct 11, 2022 | News
Harm Reduction Therapeutics Signs Commercial Supply Agreement for Fast Tracked Naloxone Nasal Spray to Reverse Opioid Overdoses by Brian Shim | Aug 11, 2022 | News
Harm Reduction Therapeutics Announces that its Naloxone Nasal Spray Met its Primary Endpoints in a Phase 1 Clinical Trial by Brian Shim | Mar 1, 2022 | News
What’s Taking So Long for Naloxone to Be Made Available Over the Counter? by Brian Shim | Jan 18, 2019 | News